# Understanding Hexarelin: Insights from Recent Research on Intestinal Permeability

Canonical source: https://retacompare.com/research/understanding-hexarelin-insights-from-recent-research-on-intestinal-permeability

Growth Hormone Peptides · 2020-01-26


    Hexarelin, a larger peptide drug, shows limited intestinal permeability enhancement with common permeation enhancers. Recent research highlights the challenges in oral delivery of peptide drugs, particularly larger molecules like hexarelin. This study investigates the effects of permeation enhancers on the intestinal absorption of hexarelin, aiming to identify effective strategies for improving its bioavailability.

 What this study examined

The study focused on the in vivo effects of transcellular permeation enhancers, specifically sodium dodecyl sulfate (SDS) and caprate, on the intestinal permeability of two peptide drugs: enalaprilat and hexarelin. Conducted using a single-pass perfusion model in rats, the research aimed to determine how these enhancers affect the absorption of hexarelin, which has a molecular weight of 887 Da, compared to enalaprilat, a smaller peptide with a molecular weight of 349 Da. The researchers tested different concentrations of caprate (5, 10, and 20 mg/mL) and pH levels (6.5 and 7.4) to assess their impact on permeability.

 Why it matters for Hexarelin research

The findings from this study are significant for hexarelin research, as they reveal the limitations of current permeation enhancers in facilitating the oral delivery of larger peptide drugs. Despite the successful enhancement of intestinal permeability for enalaprilat, hexarelin did not exhibit similar benefits, indicating a potential barrier in its absorption. This lack of efficacy may explain the challenges faced in developing oral formulations for peptide drugs, which often rely on such enhancers for improved bioavailability. The results underscore the need for innovative drug delivery strategies tailored to larger peptides like hexarelin.

 Key findings

Hexarelin did not show enhanced intestinal absorption with SDS or caprate.

Caprate required doses above its saturation concentration to potentially improve absorption.

Enalaprilat's absorption increased significantly with SDS and caprate at pH 7.4.

The study utilized a single-pass perfusion model in rats to assess drug permeability.

The findings highlight the challenges of oral delivery for larger peptide drugs.

More effective drug delivery strategies are needed for peptides like hexarelin.

 How Hexarelin works (background)

Hexarelin is a synthetic peptide that belongs to the growth hormone secretagogue family, known for its ability to stimulate the secretion of growth hormone (GH) from the pituitary gland. It acts on the growth hormone secretagogue receptor (GHS-R), which is primarily located in the hypothalamus and pituitary gland. By binding to this receptor, hexarelin promotes GH release, leading to various physiological effects, including increased muscle mass, improved metabolism, and enhanced recovery. However, the larger size of hexarelin compared to smaller peptides presents challenges in oral bioavailability, as evidenced by the study's findings on permeability enhancers.

 Practical takeaways for researchers

Researchers focusing on hexarelin should consider the implications of the study's findings regarding intestinal permeability. The lack of enhancement in absorption with common permeation enhancers suggests that alternative strategies may be necessary for effective oral delivery of hexarelin. Investigating novel formulations or delivery systems that can improve the bioavailability of larger peptides could be a fruitful avenue for future research. Additionally, understanding the mechanisms behind peptide absorption and the factors influencing permeability will be crucial in developing successful oral peptide therapies.

 FAQ

 What is Hexarelin used for?

Hexarelin is primarily researched for its role in stimulating growth hormone secretion, which may have applications in muscle growth, recovery, and metabolic enhancement.

 Why is oral delivery of Hexarelin challenging?

The larger molecular size of hexarelin compared to smaller peptides limits its intestinal permeability, making oral delivery more difficult.

 Are there effective delivery methods for Hexarelin?

Current research indicates that traditional permeation enhancers have limited effectiveness for hexarelin, highlighting the need for innovative delivery strategies.

 Source: PubMed · Pharmaceutics · published 2020-01-26.

## Sources

- PubMed · Pharmaceutics: https://pubmed.ncbi.nlm.nih.gov/31991924/